{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:00:16Z","timestamp":1780563616699,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,22]],"date-time":"2014-02-22T00:00:00Z","timestamp":1393027200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-99","type":"journal-article","created":{"date-parts":[[2014,2,22]],"date-time":"2014-02-22T06:02:17Z","timestamp":1393048937000},"source":"Crossref","is-referenced-by-count":26,"title":["Case report: passive transfer of hepatitis B antibodies from intravenous immunoglobulin"],"prefix":"10.1186","volume":"14","author":[{"given":"Simon","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Reyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,22]]},"reference":[{"issue":"5 Suppl","key":"3048_CR1","doi-asserted-by":"publisher","first-page":"S156","DOI":"10.1002\/hep.22945","volume":"49","author":"JH Hoofnagle","year":"2009","unstructured":"Hoofnagle JH: Reactivation of hepatitis B. Hepatology. 2009, 49 (5 Suppl): S156-S165.","journal-title":"Hepatology"},{"issue":"1","key":"3048_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","author":"European Association For The Study Of The Liver","year":"2012","unstructured":"European Association For The Study Of The Liver: EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012, 57 (1): 167-185.","journal-title":"J Hepatol"},{"issue":"2","key":"3048_CR3","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/hep.21841","volume":"46","author":"T Stroffolini","year":"2007","unstructured":"Stroffolini T, Gaeta GB, Mele A: AASLD practice guidelines on chronic hepatitis B and HBV infection in Italy. Hepatology. 2007, 46 (2): 608-609. author reply 609","journal-title":"Hepatology"},{"issue":"7","key":"3048_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.7326\/0003-4819-148-7-200804010-00008","volume":"148","author":"R Loomba","year":"2008","unstructured":"Loomba R, Rowley A, Wesley R, Liang TJ, Hoofnagle JH, Pucino F, et al: Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med. 2008, 148 (7): 519-528. 10.7326\/0003-4819-148-7-200804010-00008.","journal-title":"Ann Intern Med"},{"issue":"5","key":"3048_CR5","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/annonc\/mdq583","volume":"22","author":"AM Evens","year":"2011","unstructured":"Evens AM, Jovanovic BD, Su YC, Raisch DW, Ganger D, Belknap SM, et al: Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports. Ann Oncol. 2011, 22 (5): 1170-1180. 10.1093\/annonc\/mdq583.","journal-title":"Ann Oncol"},{"issue":"3","key":"3048_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00277-009-0806-7","volume":"89","author":"SN Pei","year":"2010","unstructured":"Pei SN, Chen CH, Lee CM, Wang MC, Ma MC, Hu TH, et al: Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients. Ann Hematol. 2010, 89 (3): 255-262. 10.1007\/s00277-009-0806-7.","journal-title":"Ann Hematol"},{"issue":"2","key":"3048_CR7","first-page":"110","volume":"36","author":"J Nunes","year":"2011","unstructured":"Nunes J, Marinho RT, Fonseca JE, da Silva JA P, Velosa J: Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice. Acta Reumatol Port. 2011, 36 (2): 110-118.","journal-title":"Acta Reumatol Port"},{"issue":"2 Suppl 1","key":"3048_CR8","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.tmrv.2007.01.001","volume":"21","author":"D Anderson","year":"2007","unstructured":"Anderson D, Ali K, Blanchette V, Brouwers M, Couban S, Radmoor P, et al: Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfus Med Rev. 2007, 21 (2 Suppl 1): S9-S56.","journal-title":"Transfus Med Rev"},{"issue":"5","key":"3048_CR9","first-page":"467","volume":"115","author":"B Lichtiger","year":"1991","unstructured":"Lichtiger B, Rogge K: Spurious serologic test results in patients receiving infusions of intravenous immune gammaglobulin. Arch Pathol Lab Med. 1991, 115 (5): 467-469.","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"3048_CR10","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1128\/JCM.37.10.3423-3424.1999","volume":"37","author":"H Pelloux","year":"1999","unstructured":"Pelloux H, Fricker-Hidalgo H, Brochier G, Goullier-Fleuret A, Ambroise-Thomas P: Intravenous immunoglobulin therapy: confounding effects on serological screening for toxoplasmosis during pregnancy. J Clin Microbiol. 1999, 37 (10): 3423-3424.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"3048_CR11","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.5858\/2002-126-1237-PATAFI","volume":"126","author":"KQ Rossi","year":"2002","unstructured":"Rossi KQ, Nickel JR, Wissel ME, O\u2019Shaughnessy RW: Passively acquired treponemal antibody from intravenous immunoglobulin therapy in a pregnant patient. Arch Pathol Lab Med. 2002, 126 (10): 1237-1238.","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"3048_CR12","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/j.jaad.2011.03.032","volume":"66","author":"E Benton","year":"2012","unstructured":"Benton E, Iqbal K, Wade P, Wong T, Aarons E, Groves R: False-positive hepatitis B serology following IVIG therapy: forgotten but not gone!!. J Am Acad Dermatol. 2012, 66 (3): e123-e124. 10.1016\/j.jaad.2011.03.032.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"3048_CR13","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1111\/j.1537-2995.2010.02766.x","volume":"50","author":"DM Arnold","year":"2010","unstructured":"Arnold DM, Crowther MA, Meyer RM, Carruthers J, Ditomasso J, Heddle NM, et al: Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia. Transfusion. 2010, 50 (12): 2577-2581. 10.1111\/j.1537-2995.2010.02766.x.","journal-title":"Transfusion"},{"issue":"7","key":"3048_CR14","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/j.1365-2036.2006.03081.x","volume":"24","author":"HE Kohrt","year":"2006","unstructured":"Kohrt HE, Ouyang DL, Keeffe EB: Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Aliment Pharmacol Ther. 2006, 24 (7): 1003-1016. 10.1111\/j.1365-2036.2006.03081.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3048_CR15","first-page":"56","volume":"14","author":"A Altindag","year":"2009","unstructured":"Altindag A, Cadirci D, Sirmatel F: Depression and health related quality of life in non-cirrhotic chronic hepatitis B patients and hepatitis B carriers. Neurosciences (Riyadh). 2009, 14 (1): 56-59.","journal-title":"Neurosciences (Riyadh)"},{"issue":"3","key":"3048_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2190\/D37Y-X0JY-39MJ-PVXQ","volume":"36","author":"M Ozkan","year":"2006","unstructured":"Ozkan M, Corapcioglu A, Balcioglu I, Ertekin E, Khan S, Ozdemir S, et al: Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C. Int J Psychiatry Med. 2006, 36 (3): 283-297. 10.2190\/D37Y-X0JY-39MJ-PVXQ.","journal-title":"Int J Psychiatry Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-99.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-99\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-99","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-99.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T10:44:42Z","timestamp":1648377882000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-99"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,22]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3048"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-99","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,22]]},"article-number":"99"}}